FDA Inspection 1036915 — American National Red Cross

American National Red Cross — FEI 1000148123

The FDA completed an inspection of American National Red Cross on December 6, 2017 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 6, 2017
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Washington, DC (United States)